跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 45,538 条关于
“Transpire Bio Inc.”
全部
45,538
临床试验
13,790
药物
2,572
机构
6,339
资讯
22,837
去年
Transpire Bio Licenses PDE4 Inhibitor ITG-1052 for Idiopathic Pulmonary Fibrosis Treatment
4个月前
Transpire Bio Achieves FDA Filing Acceptance for Generic High-Strength Trelegy Ellipta with Potential 180-Day Market Exclusivity
12个月前
Transpire Bio Achieves FDA Filing Acceptance for Generic Breo Ellipta, Positioning for Market Exclusivity
11个月前
US Orphan Drug Market Poised to Exceed $190 Billion by 2030 as FDA Designations Accelerate Rare Disease Therapy Development
8个月前
Transpire Bio Achieves First Human Dosing Milestone for Novel CNS Inhalation Therapy
11个月前
Transpire Bio Receives FDA Orphan Drug Designation for Inhaled Therapies Targeting IPF and Glioblastoma
去年
Transpire Bio Expands R&D and Manufacturing Footprint in Florida to Support Inhaled Therapeutics Pipeline
去年
INmune Bio's XPro Shows Promise in Alzheimer's, Faces Financial Hurdles
去年
OmniScience and INmune Bio Partner to Accelerate Alzheimer's Clinical Trial with AI
去年
Annovis Bio's Buntanetap Shows Promise in Neurodegenerative Disease Treatment
第 1 页,共 2284 页
上一页
下一页